Nonmedical influences on the use of cholinesterase inhibitors in dementia care

被引:19
作者
Franz, Carol E.
Barker, Judith C.
Kravitz, Richard L.
Flores, Yvette
Krishnan, Sheila
Hinton, Ladson
机构
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Calif Davis, Davis, CA 95616 USA
关键词
cholinesterase inhibitors; cognitive enhancers; primary care; dementia treatment;
D O I
10.1097/WAD.0b013e3181461955
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined primary care physicians' (PCPs) attitudes toward cholinesterase inhibitors (ChEI) to better understand nonmedical factors influencing prescribing decisions in dementia care. In a cross-sectional, qualitative study, 40 PCPs were interviewed concerning their general approach to managing patients with dementia, and their care for a particular dementia case. Three readers independently identified and categorized themes associated with prescribing ChEI. Physicians' attitudes toward ChEI were also coded. Physicians were predominantly ambivalent (51%) or negative (31%) about prescribing ChEI for their patients with dementia. Nonmedical factors affecting prescribing included lack of knowledge, dependence on specialists, influence of family wishes and involvement, and physicians' values. PCPs reported that lack of knowledge and experience made prescribing decisions for ChEI challenging. Physicians reported feeling pressured by families to prescribe ChEI. Under these ambiguous conditions, some physicians prescribed medications simply to be able to offer "something" to patients.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 49 条
[1]   Physicians' perspectives on caring for cognitively impaired elders [J].
Adams, WL ;
McIlvain, HE ;
Geske, JA ;
Porter, JL .
GERONTOLOGIST, 2005, 45 (02) :231-239
[2]  
*AM MED ASS, 1999, PRACT GUID PRIM CAR
[3]   Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial [J].
Ballard, C ;
Margallo-Lana, M ;
Juszczak, E ;
Douglas, S ;
Swann, A ;
Thomas, A ;
O'Brien, J ;
Everratt, A ;
Sadler, S ;
Maddison, C ;
Lee, L ;
Bannister, C ;
Elvish, R ;
Jacoby, R .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7496) :874-877
[4]  
Bentham P, 2004, LANCET, V363, P2105
[5]   Screening for dementia: Recommendation and rationale [J].
Berg, AO ;
Allan, JD ;
Frame, P ;
Homer, CJ ;
Johnson, MS ;
Klein, JD ;
Lieu, TA ;
Mulrow, CD ;
Orleans, CT ;
Peipert, JF ;
Pender, NJ ;
Siu, AL ;
Teutsch, SM ;
Westhoff, C ;
Woolf, SH .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (11) :925-926
[6]  
Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]
[7]   Implementing a screening and diagnosis program for dementia in primary care [J].
Boustani, M ;
Callahan, CM ;
Unverzagt, FW ;
Austrom, MG ;
Perkins, AJ ;
Fultz, BA ;
Hui, SL ;
Hendrie, HC .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 (07) :572-577
[8]   Screening for dementia in primary care: A summary of the evidence for the US Preventive Services Task Force [J].
Boustani, M ;
Peterson, B ;
Hanson, L ;
Harris, R ;
Lohr, KN .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (11) :927-937
[9]   What is the best dementia screening instrument for general practitioners to use? [J].
Brodaty, H ;
Low, LF ;
Gibson, L ;
Burns, K .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14 (05) :391-400
[10]  
CALLAHAN C, 2006, JAMA-J AM MED ASSOC, V10, P2148